Commentary on "Pediatric Idiopathic Steroid-sensitive Nephrotic Syndrome Diagnosis and Therapy - Short Version of the Updated German Best Practice Guideline (S2e)"

Overview

Journal Pediatr Nephrol

Specialties Nephrology
Pediatrics

Date 2021 Jun 6

PMID 34091755

Citations 1

Authors

Rasmus Ehren

Marcus R Benz

Paul T Brinkkotter

Jorg Dotsch

Wolfgang R Eberl

Jutta Gellermann

Peter F Hoyer

Isabelle Jordans

Clemens Kamrath

Markus J Kemper

Kay Latta

Dominik Muller

Jun Oh

Burkhard Tonshoff

Stefanie Weber

Lutz T Weber

Affiliations

Soon will be listed here.

Citing Articles

To biopsy or not to biopsy a teenager with idiopathic nephrotic syndrome? Biopsy first.

Bigatti C, Chiarenza D, Angeletti A Pediatr Nephrol. 2024; 40(2):571-578.

PMID: 39251432 PMC: 11666677. DOI: 10.1007/s00467-024-06510-6.

References

BRODEHL J, Brandis M, Helmchen U, Hoyer P, Burghard R, Ehrich J . Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis. Klin Wochenschr. 1988; 66(22):1126-37. DOI: 10.1007/BF01727848. View

Hoyer P, BRODEHL J, Ehrich J, Offner G . Practical aspects in the use of cyclosporin in paediatric nephrology. Pediatr Nephrol. 1991; 5(5):630-8. DOI: 10.1007/BF00856658. View

Kamei K, Ito S, Nozu K, Fujinaga S, Nakayama M, Sako M . Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children. Pediatr Nephrol. 2009; 24(7):1321-8. DOI: 10.1007/s00467-009-1191-0. View

Ravani P, Lugani F, Pisani I, Bodria M, Piaggio G, Bartolomeo D . Rituximab for very low dose steroid-dependent nephrotic syndrome in children: a randomized controlled study. Pediatr Nephrol. 2020; 35(8):1437-1444. DOI: 10.1007/s00467-020-04540-4. View

Chan E, Webb H, Yu E, Ghiggeri G, Kemper M, Ma A . Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomes. Kidney Int. 2019; 97(2):393-401. DOI: 10.1016/j.kint.2019.09.033. View

Feneberg R, Schaefer F, Zieger B, Waldherr R, Mehls O, Scharer K . Percutaneous renal biopsy in children: a 27-year experience. Nephron. 1998; 79(4):438-46. DOI: 10.1159/000045090. View

Davison A, LAMBIE A, Verth A, Cash J . Salt-poor human albumin in management of nephrotic syndrome. Br Med J. 1974; 1(5906):481-4. PMC: 1633536. DOI: 10.1136/bmj.1.5906.481. View

Webb N, Woolley R, Lambe T, Frew E, Brettell E, Barsoum E . Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation. BMJ. 2019; 365:l1800. PMC: 6531851. DOI: 10.1136/bmj.l1800. View

Wu B, Mao J, Shen H, Fu H, Wang J, Liu A . Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing. Nephrology (Carlton). 2014; 20(1):18-24. DOI: 10.1111/nep.12351. View

10.

Ehren R, Benz M, Brinkkotter P, Dotsch J, Eberl W, Gellermann J . Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy -short version of the updated German best practice guideline (S2e) - AWMF register no. 166-001, 6/2020. Pediatr Nephrol. 2021; 36(10):2971-2985. PMC: 8445869. DOI: 10.1007/s00467-021-05135-3. View

11.

. Chapter 3: Steroid-sensitive nephrotic syndrome in children. Kidney Int Suppl (2011). 2014; 2(2):163-171. PMC: 4089737. DOI: 10.1038/kisup.2012.16. View

12.

Gellermann J, Weber L, Pape L, Tonshoff B, Hoyer P, Querfeld U . Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome. J Am Soc Nephrol. 2013; 24(10):1689-97. PMC: 3785276. DOI: 10.1681/ASN.2012121200. View

13.

Christian M, Maxted A . Optimizing the corticosteroid dose in steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2021; 37(1):37-47. PMC: 7896825. DOI: 10.1007/s00467-021-04985-1. View

14.

Sheikh S, Mishra K, Kumar M . Low-dose versus conventional-dose prednisolone for nephrotic syndrome relapses: a randomized controlled non-inferiority trial. Pediatr Nephrol. 2021; 36(10):3143-3150. DOI: 10.1007/s00467-021-05048-1. View

15.

Hodson E . The management of idiopathic nephrotic syndrome in children. Paediatr Drugs. 2003; 5(5):335-49. DOI: 10.2165/00128072-200305050-00006. View

16.

Sinha A, Saha A, Kumar M, Sharma S, Afzal K, Mehta A . Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome. Kidney Int. 2014; 87(1):217-24. DOI: 10.1038/ki.2014.240. View

17.

Schijvens A, van der Weerd L, van Wijk J, Bouts A, Keijzer-Veen M, Dorresteijn E . Practice variations in the management of childhood nephrotic syndrome in the Netherlands. Eur J Pediatr. 2021; 180(6):1885-1894. PMC: 8105198. DOI: 10.1007/s00431-021-03958-8. View

18.

Samuel S, Flynn R, Zappitelli M, Dart A, Parekh R, Pinsk M . Factors influencing practice variation in the management of nephrotic syndrome: a qualitative study of pediatric nephrology care providers. CMAJ Open. 2017; 5(2):E424-E430. PMC: 5498309. DOI: 10.9778/cmajo.20160078. View

19.

Pasini A, Benetti E, Conti G, Ghio L, Lepore M, Massella L . The Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: Part I - Diagnosis and treatment of the first episode and the first relapse. Ital J Pediatr. 2017; 43(1):41. PMC: 5399429. DOI: 10.1186/s13052-017-0356-x. View

20.

Kainth D, Hari P, Sinha A, Pandey S, Bagga A . Short-Duration Prednisolone in Children with Nephrotic Syndrome Relapse: A Noninferiority Randomized Controlled Trial. Clin J Am Soc Nephrol. 2021; 16(2):225-232. PMC: 7863637. DOI: 10.2215/CJN.06140420. View